US Stock MarketDetailed Quotes
IDYA IDEAYA Biosciences
- 37.130
- -0.490-1.30%
Close Apr 19 16:00 ET
- 37.130
- 0.0000.00%
Post 16:20 ET
2.77BMarket Cap-18943P/E (TTM)
38.300High36.580Low726.14KVolume37.380Open37.620Pre Close26.98MTurnover0.98%Turnover RatioLossP/E (Static)74.56MShares47.73552wk High4.46P/B2.74BFloat Cap17.70052wk Low--Dividend TTM73.78MShs Float47.735Historical High--Div YieldTTM4.57%Amplitude2.950Historical Low37.152Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
IDEAYA Biosciences Stock Forum
NEWS!
Another run soon?
starting to look good from a rookie persoe tive. Thanks in advance.
Did you get in
Thanks to peeps pushing me to be better.
PT $24 by analysis
ColumnsUS Top Rating Updates on 12/30: NFLX, IDYA, GNRC, AMTI and More
CFRA analyst Kenneth Leon double upgraded $Netflix(NFLX.US)$ to Buy from Sell with a price target of $310, up from $225. The analyst believes it "will be difficult for competitors to catch" Netflix, noting it is one of the few profitable streaming providers with global scale.
Capital One Starts Ideaya Biosciences at Overweight With $29 Price Target
Capital One analyst Zegbeh Jallah initiated...
ColumnsToday's Pre-Market Stock Movers: BMY, ADBE, MSTR, AZN and More
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US)$ +11.3%, $Cardiff Oncology(CRDF.US)$ +9%, $Immatics(IMTX.US)$ +8.3%, $IDEAYA Biosciences(IDYA.US)$ +8%, $Lyra Therapeutics(LYRA.US)$ +5.7%, $POINT Biopharma(PNT.US)$ +5.7%, $Edgewise Therapeutics(EWTX.US)$ +4.7%, $Concert Pharmaceuticals(CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US)$ +3.2%, $Veracyte(VCYT.US)$ +2.6%, $SpringWorks Therapeutics(SWTX.US)$ +2.3%,...
ColumnsToday's Pre-Market Stock Movers: DWAC, BBBY, ILMN, DBX and More
In reaction to earnings/guidance:
• $United Microelectronics(UMC.US)$ +0.8% (August revs)
Other news:
• $ChannelAdvisor(ECOM.US)$ +54.4% (to be acquired for $23.10 per share)
• $IVERIC bio(ISEE.US)$ +42.3% (topline data from Zimura GATHER2 phase 3 clinical trialingeographic atrophy)
• $Monte Rosa Therapeutics(GLUE.US)$ +10% (receives FDA clearance of Investigational New Drug Application for MRT-2359)
• $IDEAYA Biosciences(IDYA.US)$ +4.9% (re...
ColumnsToday's pre-market stock movers: TCOM, OXY, SAVE, GS and more
• $Kezar Life Sciences(KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $Sutro Biopharma(STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $Ceragon(CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $Trip.com(TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $Apyx Medical(APYX.US)$ +8% (anno...
No comment yet